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Many cancers in the skin arise from aberrant hair follicle stem cells. WNT (wingless related 
mouse mammary tumor virus) signaling is important in regulating these stem cells, as well as 
in initiating the growth phase of the hair cycle (anagen). Follicular localization sites 
(including hair follicle stem cells) of several WNT signaling molecules are similar to those of 
synthesis enzymes of retinoic acid (RA), a vitamin A metabolite. As vitamin A and 
metabolites (retinoids/RA) are essential for growth, vision, reproduction, cell proliferation, 
differentiation, and apoptosis, exogenous retinoid treatments are currently used for various 
human skin diseases. However, the specific effects of endogenous retinoids (particularly RA) 
on hair follicles remain uncertain. To gain a better understanding of how RA interacts with 
WNT signaling, we performed 3 preliminary studies. First, we analyzed the localization of ß-
catenin in hair follicles of mice, as nuclear ß-catenin marks sites of WNT signaling. Mice 
were wax-stripped to synchronize the hair cycle and tissues were collected. 
Immunohistochemistry (IHC) determined that nuclear ß-catenin peaked 6 days after wax 
stripping, when hair was in mid-anagen. Second, we determined a drug and dose that 
topically inhibited RA synthesis, and whether this inhibition affected WNT signaling.  
Additional mice were wax-stripped, and 6 days later, 4 doses of citral or disulfiram were 
applied to this area.  IHC determined that the highest dose of each drug best inhibited RAR-
ß, a RA target gene, and citral provided stronger inhibition overall. However, citral did not 
completely inhibit RA synthesis, indicating that further studies should be conducted using 
higher doses in order to determine the optimal amount to accomplish this.  IHC analysis on 
the dorsal skin tissue from these mice also found that when RA is inhibited, WNT signaling 
is active.  Third, we determined the easiest and most cost effective manner to measure WNT 
signaling.  Two additional mice were wax stripped, and 6 days later, dorsal skin was 
5 
 
collected.  IHC determined that the ß-galactosidase antibody provided an easier way to 
determine active WNT signaling when compared to nuclear ß-catenin localization.  A large-
scale experiment, analyzing the effects of topically applied RA inhibitors on WNT signaling, 
can be performed once the optimal dose is determined. Interactions between RA and WNT 
signaling may impact the development of treatments for hair diseases and skin cancer. 
 
Introduction 
 Vitamin A (retinol) and its active derivatives (retinoids/retinoic acid) are essential for 
maintenance of several tissues, including the skin and hair (Wolbach and Howe, 1925).  
While deficiency modifies stem cell function, re-administration of vitamin A (Wolbach and 
Howe, 1933) causes the modified cells to undergo apoptosis.  These observations 
demonstrate the importance of maintaining the recommended amounts of vitamin A in cells 
and have led to the use of exogenous retinoid treatments for various human skin diseases 
(Jones, 2005).  However, the specific effects of endogenous retinoids on hair follicles remain 
uncertain.  Hair follicles are constantly cycling from anagen (growing phase) through catagen 
(regression), and into telogen (resting) (Stenn and Paus, 2001; Alonso and Fuchs, 2006).  
Wingless related mouse mammary tumor virus (WNT) signaling is essential for initiation of 
the growing phase of the hair cycle (Lo Celso et al., 2004; Shimizu and Morgan, 2004).  
Previous work conducted in this laboratory demonstrated the detailed localization patterns of 
retinoic acid (RA) biosynthesis enzymes and signaling components throughout the murine 
hair cycle (Everts et al, 2007).  Considering that these sites of expression are similar to those 
of several WNT signaling molecules (Reddy et al., 2001) and RA interacts with WNT 
signaling in other tissues and cell lines (DasGupta and Fuchs, 1999; Huelsken et al., 2001; 
Reddy et al., 2001; Lo Celso et al., 2003; Shimizu and Morgan, 2004), RA may also interact 
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with WNT signaling in the hair follicle.  Therefore, the overall objective of my thesis is to 
study the effects of RA on WNT signaling in the hair follicles of mice.  My hypothesis is that 
the presence of retinoic acid (RA) will inhibit WNT signaling.  To gain a better 
understanding of how RA interacts with WNT signaling, we performed three preliminary 
studies: 1) Determined where and when during the hair cycle nuclear ß-catenin co-localizes 
with RA synthesis; 2) Determined a drug and dose that inhibits RA synthesis in the skin in 
order to determine if RA inhibits WNT signaling; 3) Determined the easiest and most cost 





Hairs are mini-organs that are maintained through a cyclic process that includes 
periodic stem-cell dependent regeneration of hair follicles throughout adult life (reviewed in 
Stenn and Paus, 2001; Alonso and Fuchs, 2006).  The hair follicle (HF) consists of a 
permanent portion from the bulge upward, and a lower portion that cycles between  
phases of rapid growth (anagen), regression (catagen), and rest (telogen) in order to produce 
new hairs (Figure 1).  Throughout anagen (Figure 2), an entire hair shaft from tip  
to root is produced, while two thirds of the cycling portion of the HF undergoes apoptosis 
during catagen.  Telogen consists of a resting period in which the stem cells of the follicles 
prepare for a signal that begins the growth of another shaft, or the next anagen phase.  Studies 
have been conducted on these three major phases of the HF cycle in humans (Kligman, 1959), 
as well as in many mouse strains (Orwin et al, 1967; Panteleyev et al, 1998, 1999).  A 
comprehensive guide on murine (mouse) HF cycling was established by Paus and colleagues 
in 2001 (Muller-Rover et al, 2001).  This guide summarizes criteria for recognizing distinct 






































































Figure 2:  Description of an anagen follicle 




fundamental histological and ultrastructural studies on murine cycling hair follicles 
(Wolbach, 1951; Chase et al, 1951).  These staging guides are also relevant for human hair, 
as equivalent critical follicle transformations occur in mice and humans (Kligman, 1959).  
The guides indicate that there are six major and three substages of anagen, eight stages of 
catagen, and the resting phase of telogen (Muller-Rover et al, 2001).  As HF are sometimes 
inhibited from entering anagen after telogen during cycling, two functional phases of telogen 
exist: competent and refractory (Plikus et al, 2008), which will be discussed later in further 
detail. 
 The hair cycle is regulated through growth factors of the specialized dermal cells (that 
make up the dermal papilla) interacting with the epithelial stem cells, the epithelial matrix, 
and pre-cortical cells (reviewed in Stenn and Paus, 2001).  The two possible resting phases of 
telogen determine whether a HF will transition from telogen to anagen.  Competent telogen 
allows for anagen re-entry and regeneration of a new hair, while refractory telogen arrests the 
follicle in this stage (Plikus et al, 2008).  Re-entry into anagen is required for growth of a 
new hair, and ultimately involves activation of epithelial stem cells (reviewed in Stenn and 
Paus, 2001; Alonso and Fuchs, 2006).  These stem cells are thought to reside in the base of 
the upper half of the HF, in an area known as the bulge (Cotsarelis et al, 1990; Oshima et al., 
2001; reviewed in Alonso and Fuchs, 2003).  The bulge is located within the outer root 
sheath (ORS) just below the opening of the sebaceous gland, and serves as the attachment 
site for the arrector pili muscle (Montagna, 1962).  As this area marks the lower end of the 
permanent portion of the HF, the matrix cells (keratinocytes) below it are thought to begin 
cycling through the phases of the hair cycle according to the “bulge activation hypothesis” 
(Cotsarelis, et al., 1990; reviewed in Alonso and Fuchs, 2003).  The dermal papilla resides in 
the lower portion of the HF just below the epithelium, and undergoes hair-cycle dependent 
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changes in its volume, appearance, and activity (Montagna, 1962).  The “bulge activation 
hypothesis” suggests that bulge stem cells proliferate and migrate downward to ultimately 
surround the dermal papilla and form the bulb, only after receiving signals from specialized 
HF mesenchymal stem cells.  As bulge cells have been shown to divide before re-growth of 
the HF, this hypothesis is supported (Wilson et al., 1994).  The formation of the bulb thus 
occurs due to interactions between the dermal papilla and bulge stem cells, causing the 
normally slow-cycling bulge stem cells to rapidly divide and differentiate during late telogen 
or anagen.  After bulb formation, stem cells (now termed matrix cells) differentiate upward 
forming the inner root sheath (IRS) and hair shaft (Cotsarelis et al, 1990).  The IRS encloses 
the hair shaft in a rigid tube and guides it to the skin surface, while the outer root sheath 
(ORS) surrounds the IRS.  After a period of growth the HF then enters the regression phase 
of catagen.  Telogen sets in once full regression of the HF occurs, thus completing one cycle 
of the HF.  
There are two possible explanations for hair growth cessation.  One is that hair fiber 
production stops because the matrix cells have exhausted their proliferative capacities 
(Cotsarelis et al., 1990; Lavker et al., 1993).  This view assumes that due to their 
involvement in continuous replication, matrix cells are transit-amplifying (TA) cells derived 
from the stem cells in the bulge.  After each stem cell division, one of the two daughter cells 
leaves the bulge area and becomes a TA cell (a matrix cell; see Schofield et al., 1983).  As 
TA cells only possess transient proliferative properties, they eventually become exhausted 
and undergo terminal differentiation, or catagen (Straile et al., 1961).  The length of anagen 
is thus controlled by the matrix cells (Cotsarelis et al., 1990).  A second contrasting view is 
that stem cells in the bulge produce daughter matrix cells, and they continue to produce hair 
fibers until they are instructed to stop generating new daughter cells (Oshima et al., 2001).  
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This view thus assumes that matrix cells possess identical characteristics to multipotent stem 
cells in the bulge.  As stem cells possess unlimited proliferating abilities, they require 
instruction to stop generating new matrix cells.  
Vitamin A (retinol) and its active derivatives (retinoids) are essential for a number of 
biological activities, including growth, vision, reproduction, hematopoesis, immune system 
modulation, epithelial tissue homeostasis, and cell proliferation, differentiation, and 
apoptosis (Wolbach and Howe, 1925; reviewed in Mark et al., 2009).   These observations 
have led to the use of retinoids in the therapy of various skin diseases (Jones, 2005).  Orally 
delivered retinoids are efficiently absorbed by the intestine [reviewed in (Napoli, 1999; 
Harrison, 2005)].  Dietary retinyl esters are hydrolyzed by retinol ester hydrolases (primarily 
pancreatic triglyceride lipase) in the intestinal lumen, yielding unesterified (free) retinol and 
the corresponding fatty acid (palmitic or stearic).  Retinyl ester hydrolysis also requires the 
presence of bile salts that serve to solubilize the retinyl esters in mixed micelles and to 
activate the hydrolyzing enzymes.  Retinol is taken up by the enterocyte and and is re-
esterified through the actions of the enzyme lecithin retinal acyltransferase (LRAT), which 
catalyzes the transacylation of a fatty acyl group from lecithin to retinol.  In the intestine, 
cellular retinol-binding protein II (CRBP2), a member of the family of intracellular lipid-
binding proteins, binds retinol with high affinity.  This complex serves as a substrate for 
LRAT, thus facilitating retinol uptake into the body (reviewed in Harrison, 2005). The newly 
re-esterified retinyl ester is incorporated along with other dietary lipids into nascent 
chylomicrons that are then secreted from the enterocyte into the lymphatic system.  Nascent 
chylomicrons enter general circulation through the thoracic duct, where lipoprotein lipase 
(LPL) converts chylomicrons to chylomicron remnants (Moise et al, 2007).  About 66-75% 
of retinyl esters contained in chylomicrons are taken up by the liver.  These retinyl esters are 
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either secreted into the blood as (free) retinol bound to serum retinol-binding protein (RBP), 
or stored as retinyl ester in hepatic stellate cells.  The remaining 22-33% of the retinyl esters 
from chylomicrons are taken up by target tissues including the skin, muscle, heart, lungs, 
reproductive organs, and bone marrow.  
CRBPs function as specific carrier proteins for vitamin A metabolites (Ong et al, 
1994).  These proteins bind all-trans-retinol and are found within cells important in vitamin A 
metabolism or function.  Along with specific cellular locations of these proteins, slight 
differences in their binding to retinol suggest their different functions. In addition to being 
expressed in stellate cells of the liver, CRBP1 is expressed in many other organs and cell 
types including the kidney, eye, skin epithelia, and HF (Ong et al., 1994; Everts et al., 2007).  
This protein delivers retinol and retinal to specific binding sites within the nucleus and guides 
retinol and retinal to retinoid metabolizing enzymes, thus participating in the movement of 
retinol from the blood into target tissues (Ong et al, 1988; reviewed in Napoli, 1999). In 
contrast, CRBP2 is expressed primarily in the intestine and is therefore involved in 
the intestinal absorption of vitamin A, directing retinol to LRAT as discussed previously.  
CRBP3 is expressed in the heart, muscle, adipose, and mammary tissues (Moise et al, 2002). 
In some cases, the loss of one form of CRBP can be partly compensated for by the 
upregulation of other CRBPs.   
Circulating free retinol (bound to RBP) is taken up by target tissues and oxidized to 
retinal by retinol dehydrogenases (ROLDHs) (reviewed in Napoli, 1999).  Short-chain 
dehydrogenases/reductases (SDR family), such as dehydrogenase reductase 9 (Dhrs9), can 
additionally oxidize retinol bound to CRBP.  Dhrs9 (identified as eROLDH in Rexer and 
Ong, 2002, also known as hRoDH-E2 in Markova et al., 2003) is present in the majority of 
epithelial and epidermal cells, two sites where RA signaling is critical (Everts et al., 2005; 
13 
 
Markova et al., 2003).  Due to the ability of SDRs to oxidize CRBP-bound retinol, these 
ROLDHs are thought to be the major physiological enzymes that catalyze the conversion of 
retinol to retinal, allowing for subsequent RA synthesis (Rexer and Ong, 2002; Markova et 
al., 2003).  
Retinal is converted to RA by retinal dehydrogenases (RALDH1, 2 and 3; gene 
names Aldh1a1, Aldh1a2, Aldh1a3) (Napoli, 1999).  Cellular retinoic acid-binding proteins 
(CRABPs) are additional intracellular lipid binding proteins that bind only retinoic acid, 
despite structural similarities to CRBP (reviewed in Moise et al, 2002).  The generally 
believed function of CRABPs is to solubilize and protect RA in the cytosol.  However, 
mounting evidence suggests that they also play a role in regulating signaling by RA (Budhu 
and Noy, 2002).  CRABP2 was shown to transport RA from the cytosol to the nucleus, where 
it transfers RA to retinoic acid receptors (RARs) and enhances transcription.  Evidence 
additionally infers that CRABP1 is involved in the breakdown of RA by directing RA to the 
CYP26 family of enzymes, but this has not been directly proven (reviewed in Moise et al, 
2002). 
 RA, specifically all-trans RA (atRA), was shown to be the most physiologically 
relevant form of vitamin A in keratinocytes (Kurlandsky et al, 1994). The discovery of two 
classes of RA-binding transcriptional regulators, the retinoic acid receptors (RARs), and the 
retinoid X receptors (RXRs), explains most of the previously mentioned diverse biological 
activities of RA [reviewed in (Chambon, 1996; Leid et al., 1992)].  Three subtypes of RARs 
are known: RARalpha (RARa), RARbeta (RARb), and RARgamma (RARg) (Gigeure et al., 
1987; Petkovich et al. 1987; Chambon, 1996).  The functions of RARs were determined by 
Chambon and colleagues through knockout of the three RAR subtypes in mice, 
demonstrating that RAR is instrumental to RA signaling during embryonic development 
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(Lohnes et al., 1995).  All RAR single-null mutant males were viable but displayed some 
aspects of the postnatal and fetal vitamin A deficiency syndromes.  Unlike RAR single 
mutants, double-null mutants died either in utero or shortly after birth [reviewed in (Germain 
et al., 2006; Mark et al., 2007)].  Three subtypes of RXR (RXRalpha (a), beta(b), and 
gamma(g)) also exist (reviewed in Mark et al., 2009).  As RARs are type II nuclear receptors, 
they function along with the retinoid X receptor (RXR) by forming a heterodimeric complex.  
RAR-RXR heterodimers selectively control target gene expression and differentiation 
controlled by retinoids.  More specifically, RARg-RXRa heterodimers are necessary for 
growth arrest and endodermal differentiation. 
  As RA synthesis is associated with the aforementioned enzymes and binding 
proteins, their expression throughout the hair cycle indicates sites of RA, while the presence 
of receptors indicates putative sites of action.   One study showed the localization of RA 
biosynthesis and signaling components throughout the HF during the murine hair cycle 
(Everts et al., 2007).  Overall, all of the RAR subtypes were widely present and were 
localized in the epidermis and the HF.  RARa and RARg were ubiquitously expressed in HF 
throughout the hair cycle, while RARb showed a unique localization pattern.  The whole 
system necessary for RA synthesis and signaling was present during early to mid-anagen (II - 
IV).  Specifically, RA synthesis enzymes (Dhrs9, ALDH1a1-3) along with RARs and 
CRABP2 increased.  ALDH1a2 and RARs decreased during late anagen/early catagen (VI/I), 
but returned by late catagen (IV).  CRBPI increased during anagen VI/catagen I and 
remained intense throughout catagen VI.  RARs and Dhrs9 decreased by catagen VII in the 
cycling portion of the HF.  During telogen, RARs were prominent in the cycling portion of 
the HF.  As RA signaling and synthetic enzymes were distributed throughout and 
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surrounding the HF during the hair cycle, this suggests multiple roles for RA during this 
process.   
 Wnt genes function in short-range signaling and therefore play a role during 
development of many tissues.  They regulate cell fate, differentiation, proliferation, and 
mobility in skeletal muscle, kidney, the nervous system, and the HF (reviewed in Peifer and 
Polakis, 2000).  WNT signaling proteins are secreted factors that contain a dozen or so 
members and are grouped into two classes based on function (Reddy et al, 2001).  Class I 
WNTs exert the aforementioned effects through a canonical signaling pathway. When WNT 
is present (Figure 3), the canonical pathway begins by binding of WNTs to their frizzled (Fz) 
and low-density lipoprotein receptor-related protein receptor complexes on the cell surface.  
This binding inhibits glycogen synthase kinase-3ß (GSK-3ß), thus increasing levels of free ß-
catenin in the cell.  Disheveled protein (DVL) stabilizes cytosolic ß-catenin, allowing it to 
translocate to the nucleus.  ß-catenin is a structural component of adherens junctions in the 
cell membrane, linking E-cadherins to the cytoskeleton by binding to Į-catenin.  Once in the 
nucleus, ß-catenin forms transcriptional complexes with the N-terminus of members of the 
lymphoid enhancer factor/T cell factor (LEF/TCF) family of transcription factors.  This 
binding controls the transcription of WNT target genes (Wodarz and Nusse, 1998).  
Therefore, nuclear ß-catenin marks sites of active WNT signaling in HF.  Class II WNTs 
function via less well-known pathways and mediate proliferation, cell movements in 
gastrulation, and cell polarity (Millar et al, 1999).  Regulation of cell movements and polarity 
requires DVL but not ß-catenin.  In the absence of WNT (Figure 4), the cytoplasmic pool of 
ß- catenin that is not complexed with cadherins is rapidly phosphorylated at the N-terminus 
by GSK-3ß.  This complex is marked for proteasome degradation, resulting in its breakdown.  

























Figure 3: Canonical signaling pathway in the presence of WNT  
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morphogenesis and differentiation (Kishimoto et al., 2000).  When exposed to WNTs, dermal 
papilla cells in culture retained their ability to induce follicles when transplanted back into 
mice.  Substantial evidence suggests that ß-catenin signaling is important in epidermal 
development, homeostasis, and disease (reviewed by Fuchs et al., 2001).  Mice with HF-
specific deletion of ß-catenin (Huelsken et al., 2001) or overexpression of an inhibitor of 
WNT signaling (Andl et al., 2002) did not develop HF.  Similarly, when the WNT 
transcription factor gene, Lef-1, was ablated in the epidermis, mice did not form hair follicles 
(van Genderen et al., 1994).  On the contrary, mice overexpressing WNT signaling via a 
stabilized ß-catenin under control of keratin 14 (K14) promoter experienced de novo HF 
morphogenesis, produced an excess of HF, and developed tumors (Gat et al., 1999).  
Additionally, WNT/ß-catenin signaling plays a role in anagen initiation during the hair cycle, 
as transient activation of the ß-catenin pathway in the epithelium is sufficient to initiate the 
anagen phase to induce new HF (Lo Celso et al., 2004; Shimizu and Morgan, 2004).  
Furthermore, the first postnatal anagen does not occur in mice in which ß-catenin expression 
is not present in the skin (Huelsken et al., 2001).  In addition, an increase in WNT signaling 
in the bulge of the HF at onset of anagen in the WNT reporter mice (transgenic TOPGAL) 
was observed (DasGupta and Fuchs, 1999).  Moreover, several WNTS, including 10a and 
10b, are expressed in the epidermis of postnatal hair follicles at anagen onset, but not in 
resting follicles (Reddy et al., 2001).    
 RA has been shown to regulate WNT-signaling pathways in various tissues and cell 
lines (DasGupta and Fuchs, 1999; Huelsken et al., 2001; Reddy et al., 2001; Lo Celso et al., 
2003; Shimizu and Morgan, 2004), but no studies have examined regulation of this pathway 
in skin or hair follicles.  Additionally, the localization pattern of RA synthesis and signaling 
components during early anagen in proliferating and migrating keratinocytes was similar to 
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that of various WNT-signaling factors (Everts et al 2007, Reddy et al., 2001).  The specific 
role of RA in the hair cycle is currently under investigation, as RA has been found to have 
either antagonistic or synergistic effects on WNT signaling.  Evidence for mutual antagonism 
between ß-catenin and RA exists (Mongan and Gudas, 2007).  ß-catenin upregulates 
CYP26A1, degrading RA through oxidation and, conversely, RAR interacts with ß-catenin 
and competitively inhibits TCF binding sites in vitro (Easwaran et al, 1999; Mongan and 
Gudas, 2007).  RA was also found to inhibit WNT signaling by positively regulating the 
WNT inhibitors Disabled-2, Dkk1, and Sox1 (Shibamoto et al, 2004; Zhuang et al, 2003).  
Some of these WNT inhibitors are also upregulated in the hair follicle stem cell (Tumbar et 
al, 2004; Morris et al, 2004), suggesting that RA may be associated with stem cell regulation.  
RA has also been shown to have a synergistic effect with WNT signaling in mouse mammary 
epithelial cells (C57MG) that conditionally express WNT (Szeto et al, 2001; Tice et al, 2002) 
as well as totipotent teratocarcinoma cells (Liu et al, 2002). This association was 
accompanied by an increase in RARg by Wnt1 as well as a necessity of RA for Wnt1 
transcriptional activation.  These studies suggest that there is a complex interaction between 
RA and WNT signaling.  However, the specific effects of endogenous retinoids on hair 
follicles remain uncertain.  Research has not been conducted to determine the localization of 
WNT signaling in all 17 stages of the hair cycle.  Additionally, research focused on the 
interactions of RA and WNT falls short of explaining the specific role of RA in regulating 
the hair cycle.  Taking all of this into account, my hypothesis is that retinoic acid (RA) 
inhibits WNT signaling.  To gain a better understanding of how RA interacts with WNT 
signaling, we performed three preliminary studies: 1) Determined where and when during the 
hair cycle nuclear ß-catenin co-localizes with RA synthesis; 2) Determined a drug and dose 
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that inhibits RA synthesis in the skin in order to determine if RA inhibits WNT signaling; 3) 
Determined the easiest and most cost effective manner to measure WNT signaling.   
 
Materials and Methods 
 
Tissue acquisition for localization of WNT signaling: 
 Paraffin embedded tissue sections from 24 female C3H/HEJ mice were obtained from 
John P. Sundberg at The Jackson Laboratory (Bar Harbor, ME).  These mice were wax 
stripped in order to induce anagen and synchronize the hair cycle, as described previously 
(Everts et al., 2007). Skin samples were harvested from two C3H/HeJ wax-stripped mice at 
each of the following time points: 0, 3, 6, 9, 12, 15, 18, 21, and 24 days after depilation. 
These tissues were sectioned at 5-ȝPSODFHGRQPLFURVFRSHVOLGHVDQGVWDLQHGZLWK
hematoxylin and eosin for routine histopathologic analyses.  
 
Mice treatments for drug study: 
 Thirty-two C57BL/6J adult mice were purchased from The Jackson Laboratory (Bar 
Harbor, ME) and housed in a temperature and light-controlled room.  They were fed a chow 
diet (Harlen Tekland 7912, with vitamin A acetate at 29.63 IU/gram), unless noted below, 
provided water ad libitum, and were allowed to acclimate for at least one week before use in 
these experiments. Studies were conducted in accordance with the NIH Guide for the Care 
and Use of Laboratory Animals, and all mouse studies were approved by The Ohio State 
University IACUC.  At 9 weeks old, the mice were anesthetized with isoflurane (Abbott 
Laboratories, N Chicago, IL) and pre-treated with the analgesic carprofen (Rimadyl, Pfizer 
Inc., New York, NY) diluted to 0.5 mg/ml and injected subcutaneously at 0.1 ml/g body 
weight. All dorsal skin follicles were painted with warm wax (Surgi-wax; Ardell 
International, Los Angeles, CA) that was peeled off after hardening, thus depilating all dorsal 
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skin hair fibers and synchronizing the hair cycle.  After depilation, the mice were placed on a 
heating pad. This warmed them until they completely recovered from anesthesia, at which 
point they were returned to their housing location.  After six days, a time span determined by 
WKHORFDOL]DWLRQRIQXFOHDUȕ-catenin pilot study, the mice were anesthetized with isoflurane. 
Acetone (vehicle control) or one of 4 doses of either citral (0.01875, 0.0375, 0.075, 0.15 
nmol/g body weight; Sigma, St. Louis, MO) or dLVXOILUDPȝPROJ
body weight; Sigma) was applied to the dorsal side of each mouse under the hood.  Citral is a 
monoterpene aldehyde and competitive substrate for retinal dehydrogenase, while disulfiram 
is a sulfhydryl-group cross-linking agent, and both of these drugs are potent inhibitors of 
retinoic acid synthesis.  After topical application, the mice were placed on a heating pad and 
monitored until fully recovered from anesthesia, at which time they were returned to their 
housing location.  Four hours later mice were euthanized by CO2 inhalation. Dorsal skin was 
fixed overnight in zinc alcohol buffered paraformaldehyde, transferred to 70% ethanol, 
processed routinely, embedded in paraffin, sectioned at 5-6 µm, placed on microscope slides 
for immunohistochemistry (IHC) and routine histology, collected in RNAlater (Ambion, 
Austin, TX) for QPCR, or frozen in OTC. 
 
Transgenic mice:  
 Two additional adult mice, one Tg (Fos-lacZ) 34EFu/J mouse and one wild type (Wt) CD-
1 control were purchased from the Jackson Laboratory (Bar Harbor, ME) and housed as 
previously described.  The Tg (Fos-lacZ) 34EFu/J and Wt CD-1 mice were anesthetized with 
isoflurane and wax-stripped as previously described, thus depilating all dorsal skin hair fibers 
in order to induce and synchronize the hair cycle.   Six days after depilation (time period was 
determined by the localization of nuclear ß-catenin pilot study), the Tg (Fos-lacZ) 34EFu/J 
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and Wt CD-1 mice were euthanized by CO2 inhalation.  Dorsal skin was fixed for 
immunohistochemistry (IHC) and routine histology as previously described, collected in 
RNAlater  (Ambion, Austin, TX) for QPCR, or frozen in OTC. 
 
IHC: 
 Sections were pretreated with 3% hydrogen peroxide, blocked with 3% Bovine Serum 
Albumin (BSA) plus 1.28% normal goat serum, and incubated with primary antibody  
(Rabbit anti-beta-catenin, Cat #ABI9022 from Chemicon International, Billerica, MA;  
Rabbit anti-RAR-ß, from Santa Cruz Biotechnology Inc., Santa Cruz, CA; Rabbit anti-beta-
galactosidase, Abcam Inc., Cambridge, MA) overnight at 4ºC.  Tissues were incubated with a 
biotinylated anti-rabbit secondary antibody, an anti-biotin IgG-congugated with horseradish 
peroxidase tertiary antibody, and then were stained with 3-amino-9-ethylcarbazole (AEC) + 
substrate-chromagen (outlined in Everts et al., 2007). Hydrogen peroxide and BSA were 
obtained from Fisher Scientific (Waltham, MA), normal goat serum and secondary antibody 
were obtained from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA), tertiary 
antibody was obtained from Bethyl labs (Montgomery, TX), and AEC+ was obtained from 
Dako (Carpinteria, CA). 
 
Quantitative (Real-Time) Polymerase Chain Reaction (QPCR):  
 QPCR was conducted on the dorsal skin placed in RNAlater once collected from the 
euthanized mice. Crbp (Rbp1) and Rarb were used as indicators for retinoic acid (RA) 
activity as these are classical target genes (Napoli et al. 1991; Ruberte et al. 1993).  An 
RNeasy Fibrous Tissue Mini Kit (Qiagen Inc., Valencia, CA) was used to isolate purified 
RNA.  In place of a tissue rupter/lyser, a mini-bead beater (BioSpec Products, Bartlesville, 
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OK) was used to break up tissue, and volumes were adjusted to accommodate this.  RNA 
levels were measured on a UV/Vis spectrophotometer (nanodrop ND-1000, Thermo 
Scientific, Wilmington, DE).  Using a High-capacity cDNA reverse transcription kit (Applied 
Biosystems, Foster City, CA) and Mastercycler ep (Authorized Thermocycler from 
Eppendorf), 2 µg of this total RNA were converted to single-stranded cDNA that was 
suitable for qPCR applications.  qPCR reactions were then performed using 50 ng cDNA in 
the TaqMan Gene Expression Assay kit for Rarb and Rbp1 (Applied Biosystems, Foster 
City, CA) and the Applied Biosystems 7300 qPCR machine.  Relative expression was 
calculated using the ddCT method (outlined in Bookout et al., 2006) using Beta-actin as the 




Nuclear ß-catenin peaked 6 days after wax stripping, when the hair follicles were in 
anagen IIIc or IV.  
 To determine a specific point in the hair cycle where WNT signaling co-localized with 
RA synthesis and signaling, we performed IHC with an antibody against ß-catenin on 
previously collected mice tissue that had been wax stripped and collected every 3 days for 24 
days.  Hair follicles were then classified by stage (according to Muller-Rover et al., 2001).  
The presence of nuclear localization of ß-catenin marks sites of active WNT signaling in hair 
follicles (Figure 5, black arrowhead). This was compared to the previous localization of RA 
synthesis and signaling (Everts et al., 2007) to determine when WNT signaling co-localized 
with RA synthesis during the hair cycle.  
 During telogen (Figure 5 a-c), which was 0 or 24 days after wax-stripping, nuclear ß-
















Figure 5: IHC determination of nuclear localization and exclusion of ß–catenin in hair 
follicles throughout the hair cycle.  Nuclear localization and exclusion of ß–catenin in hair 
follicles throughout the hair cycle from C3H/HEJ mice that were wax-stripped to induce 
anagen and collected every 3 days for 24 days.  Telogen hair follicles (a-c), early anagen (II) 
hair follicles (d-f), mid-anagen (IIIc) hair follicles (g-j), late anagen (VI) hair follicles (k-l), 
and catagen V hair follicles (m-o). Black arrowhead, nuclear localization; black arrow, 






papilla.  ß-catenin was excluded from the nucleus in the dermal papilla and most outer root 
sheath, bulge cells, and cells in the sebaceous gland.  In early anagen I-IIIB (Figure 5 d-f), 
which was 3 days after wax-stripping, nuclear ß-catenin remained in the epidermis and outer 
root sheath, and appeared on the edge of the sebaceous gland and in a few bulge cells.  ß-
catenin was excluded from the nucleus in the dermal papilla, matrix cells, proliferated 
keratinocytes, and most bulge cells.  During mid-anagen IIIc-IV (Figure 5 g-j), which was 6 
days after wax-stripping, nuclear ß-catenin peaked and was strong in the outer root sheath, 
inner root sheath, bulge cells, and proliferating keratinocytes.  ß-catenin was also present in 
the nucleus in some dermal papilla and matrix cells of the bulb.  It was difficult to determine 
whether ß-catenin was excluded in most bulb cells and the sebaceous gland, as there may 
have been some background staining in these areas.  By late anagen V-VI (Figure 5 k-l), 
which was 9-15 days after wax-stripping, ß-catenin was nuclear excluded everywhere except 
the bulb and some outer root sheath and inner root sheath cells near the sebaceous gland.  In 
early catagen (I-III), which was 18 days after wax stripping, ß-catenin was nuclear excluded 
everywhere except the bulb and outer root sheath cells near the bulge.  By catagen IV-V 
(Figure 5 m-o), which was 18 days after wax stripping, ß-catenin was nuclear excluded 
everywhere in the hair follicles.  Lastly, during late catagen (VI-VIII), which was 21 days 
after wax stripping, ß-catenin remained nuclear excluded everywhere except for a few outer 
root sheath cells.  
 
Citral was the best inhibitor and resulted in WNT signaling in sebocytes.  
 To determine a drug and dose to use that topically inhibited retinoic acid (RA) synthesis, 
citral, disulfiram, or acetone (control) was applied to the dorsal side of mice 6 days after wax 
stripping, when WNT signaling peaked in the nuclear localization of ß-catenin study.  QPCR 
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analysis using either Crpp(Rbp1) or Rarb RA target genes as markers for RA activity in full 
thickness dorsal mouse skin did not provide significant differences between any of the doses 
of citral or disulfiram (data not shown).   
 The presence of RARb marks several sites of RA activity in hair follicles.  IHC 
conducted on anagen IIIc/IV hair follicles with an antibody against RARb (Figure 6 a-d) 
determined that RARb localized to the dermal papilla, outer root sheath, inner root sheath 
(Henle’s layer), bulge cells, sebaceous gland, and proliferated keratinocytes in the acetone 
control.  The highest dose of citral (0.15 nmol/g body weight; Figure 6 q-t) showed a strong 
reduction of RARb in the sebaceous gland, bulge cells, and proliferated keratinocytes.  
However, this dose did not inhibit RARb protein expression in the dermal papilla, inner root 
sheath, or outer root sheath.  Remaining doses of citral (0.075, 0.0375, and 0.01875 nmol/g 
body weight; Figure 6 e-p) did not provide significant differences in RARb expression and 
were similar to the acetone control.  No dose of citral completely inhibited RARb expression.  
The highest dose of disulfiram (4.48 ȝmol/g body weight, Figure 7 q-t) showed reduced 
RARb protein expression in the sebaceous gland compared to the control (Figure 7 a-d).  
However, this dose did not inhibit RARb in the dermal papilla, outer root sheath, inner root 
sheath (Henle’s layer), proliferated keratinocytes, or bulge cells.  Remaining doses of 
disulfiram (2.24, 1.12, and 0.56 ȝmol/g body weight) (Figure 7 e-p) did not provide 
significant differences in RARb protein expression and were similar to the acetone control. 
No dose of disulfiram completely inhibited RARb, and the highest dose was not as effective 
of an inhibitor as the highest dose of citral. 
 IHC conducted on anagen IIIc/IV hair follicles, and with an antibody against ß-catenin 
(Figure 8 a-d), showed nuclear exclusion of ß-catenin in the outer root sheath, bulge cells, 











Figure 6: IHC determination of RARb inhibition via citral compared to the acetone 
control in anagen IIIc/IV hair follicles.  RARb inhibition in anagen IIIc/IV hair follicles 
from C57BL/6J mice that had acetone (vehicle control) or 1 of 4 doses of citral topically 
applied to their dorsal skin 6 days after wax-stripping, when WNT signaling peaked in the 
previous study. Acetone (a-d), citral 0.01875 nmol/g body weight (e-h), citral 0.0375 nmol/g 
body weight (i-l), citral 0.075 nmol/g body weight (m-p), and citral 0.15 nmol/g body weight 
(q-t) in anagen IIIc/IV hair follicles.  Red color, RARb expression. For a, e, i, m, and q, bar 




















Figure 7: IHC determination of RARb inhibition via disulfiram compared to the 
acetone control in anagen IIIc/IV hair follicles.  RARb inhibition in anagen IIIc/IV hair 
follicles from C57BL/6J mice that had acetone (vehicle control) or 1 of 4 doses of disulfiram 
topically applied to their dorsal skin 6 days after wax-stripping, when WNT signaling peaked 
in the previous study. Acetone (a-d), disulfiram 0.56 ȝmol/g body weight (e-h), disulfiram 
1.12 ȝmol/g body weight (i-l), disulfiram 2.24 ȝmol/g body weight (m-p), and disulfiram 
4.48 ȝmol/g body weight (q-t) in anagen IIIc/IV hair follicles.  Red color, RA expression.  









and with an antibody against ß-catenin (Figure 8 e-h), showed nuclear ß-catenin in the bulge 
cells and sebaceous gland of the mice that received the highest doses of citral and disulfiram.  
 
Nuclear E-catenin and WNT reporter mice provided identical results. 
 To easily visualize WNT signaling in the most cost effective manner, two additional 
adult mice were wax stripped, and 6 days later, they were euthanized and dorsal skin 
collected.  ß-galactosidase in the WNT reporter mouse (TOPGAL) and nuclear ß-catenin in 
any mouse marked sites of active WNT signaling.  IHC conducted on anagen IV hair follicles 
with an antibody against ß-galactosidase (Figure 9 a-d) found strong expression of ß-
galactosidase in the bulb and inner root sheath, and faint ß-galactosidase expression in the 
bulge cells of the TOPGAL mice.  IHC conducted on anagen IV hair follicles with an 
antibody against ß-catenin (Figure 9 e-f) also showed nuclear ß-catenin in the bulb, inner 
root sheath, and bulge cells.  However, it was more difficult and time consuming to 
determine nuclear localization of ß-catenin in normal mice versus the presence of ß-
galactosidase in the transgenic reporter mice.  
 
Discussion:  
 To gain a better understanding of how RA interacts with WNT signaling, we 
performed three preliminary studies.  We found that nuclear ß-catenin peaked 6 days after 
wax stripping, when the hair follicles were in anagen IIIc or IV.  We also determined that 
citral provided the strongest inhibition of RARb, which increased WNT signaling in 
sebocytes and some bulge cells.  Furthermore, nuclear E-catenin and WNT reporter mice 





















Figure 8: IHC determination of nuclear localization and exclusion of ß-catenin in 
anagen IIIc/IV hair follicles when RA is inhibited.  Nuclear localization and exclusion of 
ß–catenin in anagen IIIc/IV hair follicles from C57BL/6J mice that were wax-stripped to 
induce anagen and had acetone control (Figure 8 a-d), the highest dose of citral (0.15 nmol/g 
body weight; Figure 8 e-h), or thHKLJKHVWGRVHRIGLVXOILUDPȝPROJERG\ZHLJKWQRW
pictured) topically applied to their dorsal skin.  Black arrowhead, nuclear localization; black 


















Figure 9: IHC determination of ß-galactosidase expression versus nuclear ß-catenin 
localization in anagen IIIc/IV hair follicles.  IHC determination of ß-galactosidase 
expression versus nuclear ß-catenin localization in anagen IIIc/IV hair follicles of a 
transgenic (TOPGAL) mouse that was wax-stripped to induce anagen and dorsal skin 
collected 6 days later. ß-galactosidase (Figure 9 a-d): red stain; ß-catenin (Figure 9 e-g): 
black arrowhead, nuclear ß-catenin localization; black arrow, nuclear ß-catenin exclusion. 




implicated in many types of cancers, these findings play a role in determining the importance 
of how RA interacts with WNT signaling.    
 As ß-catenin marks sites of active WNT signaling, we concluded that WNT signaling 
peaks 6 days after wax striping, when normal hair follicles are in mid-anagen (IIIc/IV).  
WNT signaling is strongest during mid-anagen in the differentiating inner root sheath, outer 
root sheath, bulge cells, and proliferating keratinocytes. It is also present in some dermal 
papilla and matrix cells of the bulb.  The majority of these localization sites are consistent 
with previous studies, which found that specific Wnt genes (Reddy et al., 2001; Millar et al., 
1999), nuclear ß-catenin (Tsuji et al, 2001; Ridanpaa et al., 2001; Moreno-Bueno et al., 
2001), or frizzled WNT receptors (Reddy et al., 2004) were present during mature anagen 
hair follicles.  However, no prior research has been conducted to determine the localization 
of WNT signaling in all 17 stages of the hair cycle.  We therefore wanted to perform an 
experiment that would pinpoint the exact stage during which WNT signaling was the 
strongest. RA synthesis and signaling components peaked in mid-anagen, 6 days after wax 
stripping (Everts et al., 2007), demonstrating similar localization patterns to what we found 
for WNT signaling.  These conclusions led us to collect the remainder of the dorsal mouse 
skin 6 days after wax stripping, as the overall objective of our research was to determine how 
RA altered WNT signaling.  
 IHC analysis determined that the highest dose of citral best inhibited RARb in the 
sebaceous gland, bulge cells, and proliferating keratinocytes.  As RARb marks sites of RA 
signaling, we concluded that RA signaling was inhibited in these sites.  However, the highest 
dose of citral did not provide complete inhibition of RA signaling, particularly in the dermal 
papilla, inner root sheath, and outer root sheath. It is possible that outer root sheath 
localization may be background staining, as previous studies did not find RARb in this area 
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of the hair follicle (Everts et al., 2004, 2007).  Another possible explanation for the lack of 
complete RA inhibition is that the doses for citral were not what we originally intended to 
use.  The highest dose of citral was 1000-fold lower than the lethal dose (LD) 50, or the dose 
where 50% of the mice do not survive.  These findings suggest that higher doses are 
physiologically safe to use and will most likely result in stronger RA inhibition.   Further 
studies should be conducted in order to determine the optimal amount to accomplish 
complete RA inhibition.    
 Previous studies in our lab determined that RARb has a similar co-localization pattern to 
retinal dehydrogenase1 and 2 (RALDH1 and RALDH2/ALDH1A1 and ALDH1A2), but not 
ALDH1A3 (Everts et al., 2004, 2007). During anagen and early catagen, ALDH1A1 
localized to the sebaceous gland, ALDH1A2 localized to the bulge region, and ALDH1A3 
localized to either the mesenchymal dermal papilla or epithelial pre-inner root sheath cells in 
the bulb region.  Our finding that RARb was present in the sebaceous gland and bulge cells 
of the acetone control during mid-anagen is consistent with these previous studies.  This 
allows us to assume that citral was actually inhibiting RARb in these sites, as previously 
mentioned.  However, usage of the RARb antibody is limiting, as it does not localize to all 
sites where RA synthesis and signaling components have been detected.  RARb does not co-
localize with ALDH1A3, and therefore is not present in the dermal papilla or pre-inner root 
sheath cells in the bulb.  Consequently, it is not possible to determine whether RA activity is 
inhibited in these sites.  Retinoic acid response element (RARE) reporter mice detect all RA 
signaling in hair follicles.  Therefore, the usage of these mice in future studies would allow 
for a better indication of sites where RA has been inhibited.  
 QPCR analysis of RNA from whole dorsal mouse skin did not provide significant 
differences between any of the doses of citral or disulfiram when using Crpp(Rbp1) or Rarb 
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as target genes for RA activity.  This finding may be due to the fact that whole skin RNA was 
used instead of the specific hair follicles from the dorsal tissue.  RARb does not detect all 
sites of RA signaling in the hair follicle, and the hair follicle is only a small fraction of the 
skin.  Consequently, using whole skin RNA may have diluted the amount of detectable 
RARb, thereby making it difficult to detect significant differences in RA inhibition.   
 In the acetone control mice, IHC analysis showed nuclear exclusion of ß-catenin.  In 
mice that received the highest dose of citral, IHC analysis showed nuclear ß-catenin in the 
sebaceous gland and some bulge cells.  As previously mentioned, RA was inhibited in the 
bulge cells and sebaceous glands of these mice.  Along with the fact that nuclear ß-catenin 
marks sites of active WNT signaling, these results further indicate that RA inhibits WNT 
signaling.  Our hypothesis therefore appears to be on the right track.  However, these results 
are only representative of a small sample size.  Once an optimal dose of citral is found to 
completely inhibit RA, a larger study should be performed with more mice in order to 
confirm that RA inhibits WNT signaling in a statistically significant sample size.   
 The ß-galactosidase localization pattern in the WNT reporter mice was the same as 
we saw with the ß-catenin antibody. However, it was more difficult and time consuming to 
determine nuclear localization of ß-catenin versus the presence of ß-galactosidase in the hair 
follicles.  This conclusion will help us decide which mice are best to use for future studies.  
When monetary resources are low, the ß-catenin method would be better to use, as the 
TOPGAL reporter mice are more expensive than normal mice.  On the other hand, when 
adequate monetary resources are available, the ß-galactosidase method would be better to 
use, as it takes less time to detect WNT signaling in these mice.  
 WNT/ɴ-catenin signaling is important in determining stem cell fate during the hair 
cycle, and regulates whether sebaceous glands or hair follicles are formed (Merrill et al., 
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2001; Fuchs and Horsley, 2008).  When aberrant WNT/ɴ-catenin signaling is inhibited in the 
sebaceous gland (but not other areas of the hair follicle), hair follicles form from those cells.  
However, aberrantly induced WNT/ɴ-catenin signaling in the sebaceous gland leads to 
proliferation of sebocytes at the expense of hair follicle formation.  As we observed WNT 
signaling in the sebaceous gland and some bulge cells of dorsal skin when RA was not 
present, this implies that RA normally regulates and inhibits WNT/ɴ-catenin signaling in 
these areas of the hair follicle.  This implication is supported by a previous study, which 
found that retinoic acid decreased the activity of the ɴ-catenin-LEF/TCF signaling pathway, a 
key component of the WNT signaling pathway in MCF7 breast cancer cells, retinoid-
sensitive adenomatous polyposis coli (APC)-mutant colon cancer (Caco-2) and retinoid-
sensitive APC-mutant human colon adenocarcinoma grade II (HT29) cells (Easwaran et al., 
1999).  One implication for aberrant WNT/ɴ-catenin signaling is that many tumors and 
cancers in the skin and body, as well as acne, arise from aberrant sebocyte proliferation 
(Widelitz, 2004; Fodde and Brabletz, 2007; Slavik et al., 2007; Gehrke et al., 2009; 
Zoubuoulis, 2004).  Components of the WNT/ ß-catenin signaling pathway may therefore 
serve as targets of cancer treatments (Easwaran et al., 1999; Luu, 2004; Widelitz 2004).  Our 
3 preliminary studies indicate that RA does indeed interact with WNT signaling in the hair 
follicle, and inhibition of RA increases WNT signaling in the sebaceous gland.  Further 
studies may help us better understand the quantity of RA needed to regulate WNT signaling 
in the hair follicle, thus preventing cancer and allowing for hair follicle formation.  These 
studies should be conducted with larger numbers of RARE reporter mice and higher doses of 
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